Figures computed from official regulatory filings — .
Analysttarget 61.25 USD (+3983%) · consensus 4/5 · 1 buy · 1 hold · 0 sell
Ownershipinsiders 14.8% · institutions 22.5% · short 3.6% of float
In USD · as of Oct 19, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Longeveron Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States. Its lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young and healthy adult donors which is in phase 3 clinical trial to treat hypoplastic left heart syndrome; completed phase 2a clinical trial to treat Alzheimer's disease, as well as in phase 2b clinical trial to treat aging frailty. The company was incorporated in 2014 and is headquartered in Miami, Florida.
Market information source · Oct 19, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 19, 2026
Open-market timeline · full history
24 buys17 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| Agafonova Nataliya | Other | $7.5K | SEC |
| Jhaveri Nirav S. | Other | $1.9K | SEC |
| Willard Stephen H | Other | $5.1K | SEC |
| Lehr Paul T | Other | $5.8K | SEC |
| Blass Devin | Other | $6.5K | SEC |
| Jhaveri Nirav S. | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Hare Joshuatrack record | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Hajjar Roger Joseph | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Ascheim Deborah | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Paletta George A. Jr. | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Cann Leah Rush | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Desai Arjun JJ | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Ungaro Ursula | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Soffer Rocktrack record | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Lehr Paul T | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Blass Devin | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Agafonova Nataliya | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Hare Joshuatrack record | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Hare Joshuatrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Lehr Paul T | Other | $9.6K | SEC |
| Locklear Lisa | Other | $16.4K | SEC |
| Agafonova Nataliya | Other | $16.4K | SEC |
| Willard Stephen H | Other | $13.2K | SEC |
| Blass Devin | Other | $11.5K | Unusual size | SEC |
| Blass Devin | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |